Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Howard

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Therapeutic Delivery|April 9, 2015
Albumin: the next-generation delivery technologyKenneth A Howard
Expert Opinion on Drug Metabolism & Toxicology|July 31, 2020
Albumin-based drug designs for pharmacokinetic modulationDiego Pilati, Kenneth A Howard
Expert Opinion on Biological Therapy|November 24, 2007
Polycation-based nanoparticle delivery for improved RNA interference therapeuticsKenneth A Howard, Jørgen Kjems
Molecular Therapy. Nucleic Acids|January 25, 2013
Oligonucleotide delivery to the lung: waiting to inhaleJørgen Kjems, Kenneth A Howard
Drug Delivery and Translational Research|March 20, 2015
RNA interference-based therapeutics and diagnosticsDan Peer, Kenneth A Howard
Nanomedicine (London, England)|July 11, 2013
Providing the full picture: a mandate for standardizing nanoparticle-based drug deliveryKenneth A Howard, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 10, 2021
FcRn expression in cancer: Mechanistic basis and therapeutic opportunitiesImke Rudnik-Jansen, Kenneth A Howard
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 25, 2018
Targeting Biological Barriers: Turning a Wall into a Therapeutic SpringboardS Moein Moghimi, Kenneth A Howard
Therapeutic Delivery|March 17, 2021
Bioengineered solutions to improve cancer immunotherapiesOle A Mandrup, Kenneth A Howard
Nanoscale|September 3, 2014
Mucus barrier-triggered disassembly of siRNA nanocarriersTroels B Thomsen, Leon Li, Kenneth A Howard
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Therapeutic Delivery|April 9, 2015
Albumin: the next-generation delivery technologyKenneth A Howard
Expert Opinion on Drug Metabolism & Toxicology|July 31, 2020
Albumin-based drug designs for pharmacokinetic modulationDiego Pilati, Kenneth A Howard
Expert Opinion on Biological Therapy|November 24, 2007
Polycation-based nanoparticle delivery for improved RNA interference therapeuticsKenneth A Howard, Jørgen Kjems
Molecular Therapy. Nucleic Acids|January 25, 2013
Oligonucleotide delivery to the lung: waiting to inhaleJørgen Kjems, Kenneth A Howard
Drug Delivery and Translational Research|March 20, 2015
RNA interference-based therapeutics and diagnosticsDan Peer, Kenneth A Howard
Nanomedicine (London, England)|July 11, 2013
Providing the full picture: a mandate for standardizing nanoparticle-based drug deliveryKenneth A Howard, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 10, 2021
FcRn expression in cancer: Mechanistic basis and therapeutic opportunitiesImke Rudnik-Jansen, Kenneth A Howard
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 25, 2018
Targeting Biological Barriers: Turning a Wall into a Therapeutic SpringboardS Moein Moghimi, Kenneth A Howard
Therapeutic Delivery|March 17, 2021
Bioengineered solutions to improve cancer immunotherapiesOle A Mandrup, Kenneth A Howard
Nanoscale|September 3, 2014
Mucus barrier-triggered disassembly of siRNA nanocarriersTroels B Thomsen, Leon Li, Kenneth A Howard
Pageof 9